Niva Bupa Health Insurance Company Ltd
₹ 86.7
-1.86%
16 Jul
- close price
About
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India.[1]
Key Points
- Market Cap ₹ 16,037 Cr.
- Current Price ₹ 86.7
- High / Low ₹ 92.9 / 67.5
- Stock P/E 123
- Book Value ₹ 20.5
- Dividend Yield 0.00 %
- ROCE 3.45 %
- ROE 3.82 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 35.9% CAGR over last 5 years
Cons
- Stock is trading at 4.23 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of 5.64% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 851 | 1,057 | 1,413 | 1,877 | 2,853 | 4,115 | 5,374 | 6,695 | |
| 880 | 1,094 | 1,435 | 2,328 | 3,183 | 4,228 | 5,296 | 6,570 | |
| Operating Profit | -29 | -37 | -22 | -451 | -330 | -113 | 78 | 125 |
| OPM % | -3% | -3% | -2% | -24% | -12% | -3% | 1% | 2% |
| 0 | 0 | 0 | 281 | 374 | 224 | 160 | 2 | |
| Interest | 3 | 4 | 6 | -0 | -0 | -0 | -0 | -0 |
| Depreciation | 16 | 21 | 22 | 27 | 32 | 29 | 25 | -0 |
| Profit before tax | -48 | -62 | -50 | -197 | 13 | 82 | 214 | 127 |
| Tax % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -3% |
| -48 | -62 | -50 | -197 | 13 | 82 | 214 | 131 | |
| EPS in Rs | 1.17 | 0.71 | ||||||
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 36% |
| 3 Years: | 33% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 36% |
| 3 Years: | 127% |
| TTM: | -37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 6% |
| Last Year: | 4% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 981 | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 | 1,827 | 1,847 |
| Reserves | -719 | -780 | -773 | -903 | -683 | 351 | 1,231 | 1,939 |
| -0 | -0 | -0 | 250 | 250 | 250 | 250 | 250 | |
| 737 | 891 | 1,322 | 1,983 | 2,799 | 3,891 | 6,452 | 7,827 | |
| Total Liabilities | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 | 11,864 |
| 30 | 39 | 46 | 49 | 52 | 58 | 66 | 88 | |
| CWIP | 2 | 2 | 2 | 1 | 4 | 1 | 9 | -0 |
| Investments | 816 | 1,067 | 1,622 | 2,401 | 3,366 | 5,458 | 8,175 | 9,670 |
| 152 | 129 | 230 | 287 | 455 | 675 | 1,510 | 2,106 | |
| Total Assets | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 | 11,864 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 257 | 338 | 593 | 813 | 1,654 | 905 | |||
| -374 | -723 | -829 | -1,882 | -2,348 | -961 | |||
| 280 | 374 | 280 | 1,110 | 771 | -5 | |||
| Net Cash Flow | 164 | -12 | 43 | 41 | 78 | -62 | ||
| Free Cash Flow | 229 | 309 | 555 | 780 | 1,613 | 857 | ||
| CFO/OP | -1,180% | -75% | -180% | -720% | 2,121% | 725% |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Inventory Days | ||||||||
| Days Payable | ||||||||
| Cash Conversion Cycle | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Working Capital Days | -264 | -270 | -290 | -341 | -313 | -298 | -351 | -322 |
| ROCE % | -19% | -10% | -30% | 1% | 5% | 7% | 3% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Claims Settlement Ratio % |
|
||||
| GWP Contribution of New Retail Health Indemnity Policies with Sum Insured >= ₹1 million % |
|||||
| Individual Agents # |
|||||
| Network Hospitals # |
|||||
| Number of Active Lives Insured Million |
|||||
| Renewal Rate for Retail Health Indemnity Products % |
|||||
| Retail Health Market Share % |
|||||
| Preferred Partner Network (PPN) Hospitals # |
|||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Credit Rating
1d - ICRA assigned Niva Bupa issuer rating [ICRA]AAA(Stable) on July 15, 2026.
-
Disclosure Under The Regulation 30 Of SEBI (LODR) Regulations, 2015
1d - Mumbai tax authority sanctioned ₹22.12 crore refund for July 2017–September 2022 tax dispute.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Copies of newspaper publications - Information of the eighteenth Annual General Meeting of the Company
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 13 Jul
-
Closure of Trading Window
30 Jun - Trading window closed from July 1, 2026 until 48 hours after Q1 FY27 results.
Concalls
-
May 2026Transcript PPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
Leading Insurance Company: Niva Bupa Health Insurance is one of the major players among private standalone health insurers in India. In FY25, the company held a gross direct premium income (GDPI) market share of ~5.31% in the health insurance segment and 17.59% among standalone private health insurers. Co received its license from the IRDAI on Feb 15, 2010 and commenced operations in Mar 2010.[1]